Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, VIC, Australia.
Centre for Youth Mental Health, The University of Melbourne, Melbourne, VIC, Australia.
Braz J Psychiatry. 2021 May-Jun;43(3):324-336. doi: 10.1590/1516-4446-2020-0948.
Acceptance and commitment therapy (ACT) is a third-wave psychological intervention that has attracted considerable clinical and research attention. A previous meta-analysis of ACT trials in psychosis reported a large effect size of ACT against overall psychotic symptomatology. However, there were critical methodological issues in the review that justify replication.
Systematic review and meta-analysis of randomized controlled trials (RCTs) testing ACT vs. any comparator condition in a sample of adults with psychosis. The outcome of interest was overall psychotic symptomatology.
The search identified seven published and eight unpublished trials (of which we were able to obtain data from one). Data on symptomatology were extracted from six trials that involved 274 participants. The summary effect size (Hedge's G) for overall symptomatology was small and not significant (-0.21, 95%CI -0.60-0.18). Trials were generally rated as having a high risk of bias. Safety reporting was inadequate across included trials.
Our observed effect size contrasted with that reported in a previous meta-analysis; differences were likely explained by errors in data extraction. The findings of this review suggest that there is currently inadequate evidence to conclude that ACT is a safe and effective treatment against psychotic symptomatology.
CRD42018097200.
接纳与承诺疗法(ACT)是一种第三波心理干预方法,已经引起了广泛的临床和研究关注。先前对精神分裂症患者进行的 ACT 试验的荟萃分析报告称,ACT 对整体精神病症状有很大的影响。然而,该综述存在关键的方法学问题,需要进行复制。
对接受 ACT 治疗与任何对照组治疗的精神分裂症成年患者的随机对照试验(RCT)进行系统评价和荟萃分析。感兴趣的结果是整体精神病症状。
搜索结果确定了七项已发表的和八项未发表的试验(其中我们能够从一项试验中获得数据)。六项试验中提取了关于症状学的数据,涉及 274 名参与者。总体症状的综合效应大小(Hedge's G)较小且不显著(-0.21,95%CI -0.60-0.18)。试验通常被评为具有高偏倚风险。纳入的试验中安全性报告不充分。
我们观察到的效应大小与先前荟萃分析报告的结果形成对比;差异可能是由于数据提取错误所致。本综述的结果表明,目前尚无足够的证据可以得出结论,即 ACT 是一种安全有效的精神病症状治疗方法。
CRD42018097200。